Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional CO2 Laser with Insulin, Botox, or Triamcinolone for Keloids
NCT06230146Phase 2Not yet recruiting
- Sponsor
- Assiut University
- Start
- May 2024
- Primary completion
- Jan 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of human insulin in keloid, sponsored by Assiut University. Planned start May 2024; status: not yet recruiting.
02
Drugs
human insulin
03
Conditions
keloid
Beyond the preview
Go deeper on NCT06230146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06230146.